generated: '2026-08-04'
method: probed
source: https://www.lifebiosciences.com/wp-json/, live probes
api: Life Biosciences WordPress Content API
versioning:
  scheme: namespace-in-path
  current: wp/v2
  docs: null
  detail: >-
    The version is the WordPress REST namespace (`/wp-json/wp/v2/`). It moves with the site's
    WordPress core version, which Life Biosciences does not announce. Consumers get no advance
    notice of a namespace change.
deprecation:
  policy_url: null
  policy_published: false
  sunset_header: false
  deprecation_header: false
  deprecated_operations: []
  detail: No deprecation policy, no RFC 8594 Sunset/Deprecation headers observed.
sla:
  url: null
  uptime_target: null
  published: false
status_page:
  url: null
  published: false
  probed: [status.lifebiosciences.com]
  detail: No status page. status.lifebiosciences.com does not resolve. No StatusPage pointer is emitted.
support:
  url: https://www.lifebiosciences.com/contact/
  detail: >-
    A general corporate contact form. There is no developer support channel, forum, community or
    issue tracker.
change_communication:
  api_changelog: false
  detail: >-
    There is no API changelog. Corporate news is published as WordPress posts and syndicated over
    RSS — that feed is the only change signal a consumer can subscribe to, and it covers the company,
    not the API.
  feeds:
  - https://www.lifebiosciences.com/feed/
  - https://www.lifebiosciences.com/news/feed/
  latest_post_observed: {date: '2026-06-09', title: Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER-100 for Optic Neuropathies}
company_lifecycle:
  note: Non-API lifecycle context, from the company's own pages.
  stage: clinical-stage
  lead_program: {name: ER-100, indications: [open-angle glaucoma, non-arteritic anterior ischemic optic neuropathy], phase: Phase 1, ind_cleared: '2026-01-15', first_patient_dosed: '2026-06-09'}
  preclinical: [{program: metabolic liver disease, indication: MASH}]
  funding: {round: Series D, amount_usd: 80000000, announced: '2026-04-08'}
  source: https://www.lifebiosciences.com/pipeline/